Although different protein expression levels of EDIL3 were observed in these breast cancer cell lines, the statistical analysis showed that when compared with MDA-MB-468 cells, only MDA-MB-468R and MDA-MB-231 cells had a significant increase in EDIL3 protein expression (Fig. 2a). This evidence concerns the gene EDIL3 and breast carcinoma.